Genetics, clinical management and natural history of congenital hypothyroidism

Research output: Contribution to journalArticle

Abstract

Congenital hypothyroidism has an incidence of 1:3000–4000 newborns. In the past, it was a common cause of mental retardation, although newborn screening has improved the prognosis. Several transcription factors are crucial to the early organogenesis of the thyroid, including TITF1, FOXE1, PAX8 and HHEX. Nevertheless, a small minority of humans with congenital hypothyroidism carry mutations in these genes. Long-term follow-up studies show that with appropriate therapy, the mental and physical development of congenital hypothyroidism patients is in the normal range, although somewhat delayed when compared with appropriate controls. Critical issues of treatment include early diagnosis and rapid correction of hypothyroidism by ensuring rapid initiation of treatment and rapid normalization of thyroid-stimulating hormone levels, especially in cases of severe congenital hypothyroidism. There has been recent question of the need to treat premature infants with hypothyroxinemia but no elevation of the thyroid-stimulating hormone concentration. Numerous controlled studies of the short- and long-term effects of thyroid hormone supplementation have not shown a consistent benefit in this group of patients. Future research will investigate further the genetic underpinnings of the condition. There is a worldwide need to prevent congenital hypothyroidism by ensuring adequate dietary iodine and to develop infrastructure to diagnose and treat congenital hypothyroidism in developing countries.

Original languageEnglish (US)
Pages (from-to)265-279
Number of pages15
JournalExpert Review of Endocrinology and Metabolism
Volume1
Issue number2
DOIs
StatePublished - Mar 1 2006
Externally publishedYes

Fingerprint

Congenital Hypothyroidism
Thyrotropin
Newborn Infant
Organogenesis
Hypothyroidism
Thyroid Hormones
Premature Infants
Intellectual Disability
Iodine
Developing Countries
Early Diagnosis
Thyroid Gland
Reference Values
Transcription Factors
Therapeutics
Mutation
Incidence
Genes

Keywords

  • hypothyroidism
  • neonatal screening
  • newborn infant
  • premature infant
  • thyroid gland
  • thyrotropin
  • thyroxine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Genetics, clinical management and natural history of congenital hypothyroidism. / Fuqua, John.

In: Expert Review of Endocrinology and Metabolism, Vol. 1, No. 2, 01.03.2006, p. 265-279.

Research output: Contribution to journalArticle

@article{3c7acb2d4aef42aeaaf0f5b5b84a2ef9,
title = "Genetics, clinical management and natural history of congenital hypothyroidism",
abstract = "Congenital hypothyroidism has an incidence of 1:3000–4000 newborns. In the past, it was a common cause of mental retardation, although newborn screening has improved the prognosis. Several transcription factors are crucial to the early organogenesis of the thyroid, including TITF1, FOXE1, PAX8 and HHEX. Nevertheless, a small minority of humans with congenital hypothyroidism carry mutations in these genes. Long-term follow-up studies show that with appropriate therapy, the mental and physical development of congenital hypothyroidism patients is in the normal range, although somewhat delayed when compared with appropriate controls. Critical issues of treatment include early diagnosis and rapid correction of hypothyroidism by ensuring rapid initiation of treatment and rapid normalization of thyroid-stimulating hormone levels, especially in cases of severe congenital hypothyroidism. There has been recent question of the need to treat premature infants with hypothyroxinemia but no elevation of the thyroid-stimulating hormone concentration. Numerous controlled studies of the short- and long-term effects of thyroid hormone supplementation have not shown a consistent benefit in this group of patients. Future research will investigate further the genetic underpinnings of the condition. There is a worldwide need to prevent congenital hypothyroidism by ensuring adequate dietary iodine and to develop infrastructure to diagnose and treat congenital hypothyroidism in developing countries.",
keywords = "hypothyroidism, neonatal screening, newborn infant, premature infant, thyroid gland, thyrotropin, thyroxine",
author = "John Fuqua",
year = "2006",
month = "3",
day = "1",
doi = "10.1586/17446651.1.2.265",
language = "English (US)",
volume = "1",
pages = "265--279",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Genetics, clinical management and natural history of congenital hypothyroidism

AU - Fuqua, John

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Congenital hypothyroidism has an incidence of 1:3000–4000 newborns. In the past, it was a common cause of mental retardation, although newborn screening has improved the prognosis. Several transcription factors are crucial to the early organogenesis of the thyroid, including TITF1, FOXE1, PAX8 and HHEX. Nevertheless, a small minority of humans with congenital hypothyroidism carry mutations in these genes. Long-term follow-up studies show that with appropriate therapy, the mental and physical development of congenital hypothyroidism patients is in the normal range, although somewhat delayed when compared with appropriate controls. Critical issues of treatment include early diagnosis and rapid correction of hypothyroidism by ensuring rapid initiation of treatment and rapid normalization of thyroid-stimulating hormone levels, especially in cases of severe congenital hypothyroidism. There has been recent question of the need to treat premature infants with hypothyroxinemia but no elevation of the thyroid-stimulating hormone concentration. Numerous controlled studies of the short- and long-term effects of thyroid hormone supplementation have not shown a consistent benefit in this group of patients. Future research will investigate further the genetic underpinnings of the condition. There is a worldwide need to prevent congenital hypothyroidism by ensuring adequate dietary iodine and to develop infrastructure to diagnose and treat congenital hypothyroidism in developing countries.

AB - Congenital hypothyroidism has an incidence of 1:3000–4000 newborns. In the past, it was a common cause of mental retardation, although newborn screening has improved the prognosis. Several transcription factors are crucial to the early organogenesis of the thyroid, including TITF1, FOXE1, PAX8 and HHEX. Nevertheless, a small minority of humans with congenital hypothyroidism carry mutations in these genes. Long-term follow-up studies show that with appropriate therapy, the mental and physical development of congenital hypothyroidism patients is in the normal range, although somewhat delayed when compared with appropriate controls. Critical issues of treatment include early diagnosis and rapid correction of hypothyroidism by ensuring rapid initiation of treatment and rapid normalization of thyroid-stimulating hormone levels, especially in cases of severe congenital hypothyroidism. There has been recent question of the need to treat premature infants with hypothyroxinemia but no elevation of the thyroid-stimulating hormone concentration. Numerous controlled studies of the short- and long-term effects of thyroid hormone supplementation have not shown a consistent benefit in this group of patients. Future research will investigate further the genetic underpinnings of the condition. There is a worldwide need to prevent congenital hypothyroidism by ensuring adequate dietary iodine and to develop infrastructure to diagnose and treat congenital hypothyroidism in developing countries.

KW - hypothyroidism

KW - neonatal screening

KW - newborn infant

KW - premature infant

KW - thyroid gland

KW - thyrotropin

KW - thyroxine

UR - http://www.scopus.com/inward/record.url?scp=85018910002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018910002&partnerID=8YFLogxK

U2 - 10.1586/17446651.1.2.265

DO - 10.1586/17446651.1.2.265

M3 - Article

VL - 1

SP - 265

EP - 279

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 2

ER -